Scientists track patients for years after pioneering heart gene therapy
NCT ID NCT07050160
Summary
This study is a long-term follow-up for up to 10 patients who previously received an experimental gene therapy (LX2020) for a genetic heart muscle disease. The main goal is to monitor their health for four more years to check for any long-term side effects. No new treatment is given in this phase; researchers are just observing the patients who already received the therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.